Characterization and bioavailability of danazol-hydroxypropyl β-cyclodextrin coprecipitates

International Journal of Pharmaceutics

Volumn 128, Issue 1-2, 1996, Pages 45-54

  Farag Badawy, Sherif I ^a   Ghorab, Mahmoud M ^b   Adeyeye, Christianah Moji ^a  

^a DUQUESNE UNIVERSITY   (United States)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

bioavailability; complexation; coprecipitate; danazol; hydroxypropyl cyclodextrin; solub ility

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; DANAZOL;

ANIMAL EXPERIMENT; AREA UNDER THE CURVE; ARTICLE; BIOAVAILABILITY; COMPLEX FORMATION; CONTROLLED STUDY; DISSOLUTION; DRUG SOLUBILITY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PHARMACOKINETICS; PRECIPITATION; PRIORITY JOURNAL; RAT; X RAY DIFFRACTION;

EID: 0342468147     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(95)04214-8     Document Type: Article

References (20)

1. Amdidouche, D., Darrouzet, H., Duchene, D. and Poelman, M.C., Inclusion of retinoic acid in β-cyclodextrin. Int. J. Pharm., 54 (1989) 175-179.
2. Bakatselou, V., Oppenheim, R.C. and Dressman, J.B., Solubilization and wetting effects of bile salts on the dissolution of steroids. Pharm. Res., 8 (1991) 1461-1469.
3. Betlach, C.J., Gonzalez, M.A., McKiernan, B.C., Neff-Davis, C. and Bodor, N., Oral pharmacokinetics of carbamazepine in dogs from commercial tablets and a cyclodextrin complex. J. Pharm. Sci., 82 (1993) 1058-1060.
4. Davison, C., Banks, W. and Fritz, A., The absorption, distribution and metabolic fate of danazol in rats, monkeys and human volunteers. Arch. int. Pharmacodyn., 221 (1976) 294-310.
5. Dmowski, W.P., Danazol: A synthetic steroid with diverse biologic effects. J. Reprod. Med., 35(1 Suppl) (1990), 69-74, discussion 74-75.
6. Dodin, S., Lemay, A., Maheux, R., Dumont, M. and Turcot-Lemay, L., Bone mass in endometriosis patients treated with GnRH agonist implant or danazol. Obstet. Gynecol., 77 (1991) 410-415.
7. Gibaldi, M. and Perrier, D., Pharmacokinetics, 2nd edition, Marcel Dekker Inc., New York, 1982, p. 475.
8. Harrington, J.W., Sheremata, W.A., Snodgrass, S.R., Emerson, S., Philip, S. and Berger, J.R., Topical spastic paraparesis is HTLV-1-associated myelopathy (TSP/HAM): treatment with an anabolic steroid danazol. AIDS Res. Hum. Retroviruses, 7 (1991) 1031-1034.
9. Hassan, M.A., Suleiman, M.S. and Najib, N.M., Improvement of in vitro dissolution characteristics of famotidine by inclusion in β-cyclodextrin. Int. J. Pharm., 58 (1990)19-24.
10. Higuchi, T. and Connors, K.A., Phase solubility techniques. Adv. Anal. Chem. Instrum., 4 (1965) 117-212.
11. Hooper, W.D., Eadie, M.J. and Dickinson, R.G., Single oral dose pharmacokinetics and comparative bioavailability of danazol in humans. Biopharm. Drug Disp., 12 (1991) 577-582.
12. Kitamura, S., Koda, S. and Yasuda, T., Moisture adsorption-desorption effect on the structure of inclusion complex of 6-chloro-2-pyridylmethyl nitrate and β-cyclodextrin. J. Pharm. Pharmacol., 42 (1990) 611-614.
13. Krenn, M., Gamcsik, M.P., Vogelsang, G.B., Colvin, O.M. and Leong, K.W., Improvements in solubility and stability of thalidomide upon complexation with hydroxypropyl-β-cyclodextrin. J. Pharm. Sci., 81 (1992) 685-689.
14. Nerella, N.G., Block, L.H. and Noonan, P.K., The impact of lag time on the estimation of pharmacokinetic parameters. I. One-compartment open model. Pharm. Res., 10 (1993) 1031-1036
15. Nygard, G.A., Lovett, L.J., Erdmann, G.R. and Khalil, S.K.W., Analysis of danazol in serum using high-performance liquid chromatography. J. Chromatogr., 415 (1987) 438-444.
16. Pitha, J. and Hoshino, T., Effects of ethanol on formation of inclusion complexes of hydroxypropylcyclodextrins with testosterone or with methyl orange. Int. J. Pharm., 80 (1992) 243-251.
17. Simonelli, A.P., Mehta, S.C. and Higuchi, W.I., Dissolution rates of high energy sulfathiazole povidone coprecipitates II: Characterization of form of drug controlling its dissolution rate via solubility studies. J. Pharm. Sci., 65 (1976) 355-361.
18. Szejtli, J. Cyclodextrin Technology, Kluwer, Dordrecht, Holland, 1988, p. 104.
19. Usayapant, A., Karara, A.H. and Narukar, N.M., Effect of 2-hydroxypropyl-β-cyclodextrin on the occular absorption of dexamethasone and dexamethasone acetate. Pharm. Res., 8 (1991) 1495-1499.
20. Zullo, F., Colacurci, N., Carravetta, C., D'Agostino, G., Nazarro, A. and De Placido, G., Effects of danazol on the endometrium during peri-menopausal meno-metrorrhagia. Minerva Ginecologica, 43 (1991) 299-305.